The Centers for Disease Control and Prevention (CDC) and the federal Food and Drug Administration (FDA), as well as the Advisory Committee on Immunization Practices (ACIP) have authorized the Pfizer COVID-19 Booster for individuals 65 years of age and older, individuals 18-64 years of age at risk for severe COVID-19 due to underlying medical conditions, and individuals 18-64 years of age who are at increased risk for COVID-19 because of occupational or institutional settings who have previously received the Pfizer vaccine. Based on federal guidance, long-term care facility residents and staff are eligible to receive their booster shot at least 6 months after their second dose of the Pfizer COVID-19 vaccine. 

The COVID-19 vaccines are safe and effective in reducing the risk of severe disease, hospitalization, and death, including against the widely circulating Delta variant. The CDC recommends that protection from COVID-19 is improved with the addition of a booster shot, especially for individuals at higher risk including long-term care residents. Vaccinating long-term care facility residents and staff against COVID-19 is a crucial step in preventing the spread of COVID-19. 

We are coordinating booster clinics with facility and local pharmacies. Someone from the facility may contact you to confirm consent of the booster shot for your loved one.  We are including a link to the EUA (Emergency Use Authorization) for your review. Please call the facility if you have any questions or require additional information.

View All News